Kratos Defense, Fibrogen, Nike: 'Mad Money' Lightning Round

Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round" Tuesday evening:

Kratos Defense & Security (KTOS) : "I like that one and want to stay long."

FibroGen (FGEN) : "That is extremely speculative. They have no earnings."

Nike (NKE) : "I think it will be multiple quarters before they can breakout to the upside."

Allscripts Healthcare (MDRX) : "No, I like Cardinal Health (CAH) in that group."

Over on Real Money, Cramer explains what's happening in this market and what it means to your investment strategies. Get his insights with a free trial subscription to Real Money.

Cramer and the AAP team are focusing on the outlook for their charitable trust. Find out what they're telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.

To read a full recap of this episode of "Mad Money," click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

At the time of publication, Cramer's Action Alerts PLUS had no position in stocks mentioned.

More from Jim Cramer

Join Jim Cramer's Club During Our '12 Days of Holiday Deals' Sale and Save 66%!

Join Jim Cramer's Club During Our '12 Days of Holiday Deals' Sale and Save 66%!

Bargains Are Being Created: Cramer's 'Mad Money' Recap (Friday 12/14/18)

Bargains Are Being Created: Cramer's 'Mad Money' Recap (Friday 12/14/18)

Children's Place, Synchrony, Yeti and more: 'Mad Money' Lightning Round

Children's Place, Synchrony, Yeti and more: 'Mad Money' Lightning Round

Jim Cramer: Here's the State of Play as We Head Into Next Week's Action

Jim Cramer: Here's the State of Play as We Head Into Next Week's Action

Jim Cramer: I Can't Tell You to Buy This Market

Jim Cramer: I Can't Tell You to Buy This Market